Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries — Anna Norhammar (2022) | RDL Network
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries
Article 2022 en
Authors
AN
Anna Norhammar
JB
Johan Bodegård
JE
Jan W. Eriksson
Abstract
1 min read
Across all nations, HF or CKD was the most frequent CVRD manifestation to develop in a low-risk population with T2D, accounting for the highest proportion of hospital healthcare costs. These novel findings highlight the importance of cardiorenal awareness when planning healthcare.
Shuchi Anand, Yuanchao Zheng, Maria E. Montez‐Rath, Wang Jin Wei, Norberto Perico, Sergio Carminati, KM Venkat Narayan, Nikhil Tandon, Viswanathan Mohan, Vivekanand Jha, Luxia Zhang, Giuseppe Remuzzi, Dorairaj Prabahkaran, Glenn M. Chertow
Marjan Walli-Attaei, Ramón Luengo-Fernández, Alastair Gray, Aleksandra Torbica, Aldo Maggioni, Firoozeh Bairami, Radu Huculeci, Victor Aboyans, Adam Timmis, Panos E. Vardas, José Leal
Xin Yin, Wei Bao, Sylvia H. Ley, Jiaxi Yang, Sinéad Cuffe, Guoqi Yu, Jorge E. Chavarro, Peipei Liu, Juan Zhou, Deirdre K. Tobias, Frank B Hu, CUILIN ZHANG
Anna Birukov, Marta Guasch‐Ferré, Deirdre K. Tobias, Sylvia H. Ley, Clemens Wittenbecher, Jiaxi Yang, JoAnn E. Manson, Jorge E. Chavarro, Frank B Hu, CUILIN ZHANG
Discussion(0)
No comments yet. Be the first to comment.